$67.16 +0.12 (%) Baxter International Inc - NYSE

May. 28, 2015 | 02:00 PM

Partner Headlines

  1. Baxter and Baxalta Holdings Outline Vision for Accelerated and Sustainable Growth, Showcase Innovation

    Benzinga | May. 18, 2015 | 08:35AM EST
  2. Baxter buying leukemia drugs

    IBD | May. 12, 2015 | 19:01PM EST
  3. Take Steps To Become The Best You

    IBD | Apr. 28, 2015 | 14:41PM EST
  4. Akorn Downgraded, Stock Falls On 'Credibility Gap'

    IBD | Apr. 27, 2015 | 11:26AM EST
  5. Baxter

    IBD | Apr. 23, 2015 | 18:31PM EST
  6. Earnings Scheduled For April 23, 2015

    Benzinga | Apr. 23, 2015 | 04:03AM EST
  7. Cyberonics Soars On Earnings Beat, Tax Inversion Deal

    IBD | Feb. 26, 2015 | 13:58PM EST
  8. To Reinvest or Not Reinvest: That is the Question

    GuruFocus | Feb. 19, 2015 | 09:55AM EST
  9. Best Stock Pick For Long Term Investors

    GuruFocus | Feb. 10, 2015 | 14:40PM EST
  10. Richard Pzena's New Buys

    GuruFocus | Feb. 9, 2015 | 14:43PM EST
  11. Richard Pzena's 5 New Q4 Stock Buys

    GuruFocus | Feb. 7, 2015 | 00:56AM EST
  12. Baxter Int'l

    IBD | Jan. 29, 2015 | 18:38PM EST
  13. Earnings Scheduled For January 29, 2015

    Benzinga | Jan. 29, 2015 | 04:45AM EST
  14. Baxter Offers Yield In Hot Medical Products Group

    IBD | Jan. 16, 2015 | 17:47PM EST
  15. What Investors Are Expecting Ahead Of Multiple Nektar Therapeutics Catalysts

    Benzinga | Jan. 9, 2015 | 12:53PM EST
  16. Spinal Products Firm NuVasive Ripe For Expansion

    IBD | Jan. 8, 2015 | 15:17PM EST
  17. What Investors Should Expect From Rockwell Medical's Next FDA Decision

    Benzinga | Jan. 7, 2015 | 16:22PM EST
  18. Pete Najarian's Picks For 2015: Citigroup, Foot Locker And More

    Benzinga | Jan. 6, 2015 | 17:20PM EST
  19. What Investors Are Looking for After Seeing Unusual Options Activity In Halozyme

    Benzinga | Jan. 6, 2015 | 12:15PM EST
  20. Inogen Powers Up Medical Products Stocks With Oxygen

    IBD | Jan. 5, 2015 | 16:37PM EST
  21. Baxter Submits Application for U.S. FDA Approval of BAX111, Investigational Recombinant Treatment for Von Willebrand Disease

    Benzinga | Dec. 22, 2014 | 09:00AM EST
  22. Baxter Reports Filing of Form 10 Registration Statement Related to Planned Spinoff of Biopharma Unit

    Benzinga | Dec. 10, 2014 | 17:16PM EST
  23. Pfizer Spreading Its Wings Into A New Domain Of Life Sciences

    GuruFocus | Dec. 9, 2014 | 10:50AM EST
  24. Hot Drugmakers Build More Labs, Grab Space In Boston

    IBD | Dec. 4, 2014 | 16:47PM EST
  25. I think Zimmer Will Outperform S&P 500 Performance

    GuruFocus | Dec. 4, 2014 | 10:06AM EST
  26. Becton, Dickinson and Co. (BDX) Dividend Stock Analysis

    GuruFocus | Nov. 19, 2014 | 12:37PM EST
  27. Baxter tops in Q3 amid split-up

    IBD | Oct. 16, 2014 | 18:49PM EST
  28. Baxter Q3 Beats As Hemophilia Drugs Fend Off Rivals

    IBD | Oct. 16, 2014 | 15:07PM EST
  29. Earnings Scheduled For October 16, 2014

    Benzinga | Oct. 16, 2014 | 04:50AM EST
  30. UPDATE: Morgan Stanley Reiterates On Baxter International On Value Creation Through Spin

    Benzinga | Oct. 13, 2014 | 09:34AM EST
  31. UPDATE: Bank Of America Reiterates On Baxter International Inc. On Mixed Factors

    Benzinga | Oct. 6, 2014 | 07:40AM EST
  32. Baxter Gets Shot In The Arm From Rockwell Deal

    IBD | Oct. 3, 2014 | 18:09PM EST
  33. Benzinga's Top #PreMarket Gainers

    Benzinga | Oct. 3, 2014 | 08:44AM EST
  34. Medical Technology Company Offers Investment Opportunity

    GuruFocus | Sep. 25, 2014 | 16:00PM EST
  35. Stocks Gain While Dollar Reaches Highest Level Since 2010

    Benzinga | Sep. 24, 2014 | 17:03PM EST
  36. Dow Jumps 170 Points; Bed Bath & Beyond Shares Rise On Upbeat Results

    Benzinga | Sep. 24, 2014 | 15:54PM EST
  37. U.S. Stocks Rise; Accenture Shares Decline On Weak Forecast

    Benzinga | Sep. 24, 2014 | 13:17PM EST
  38. Markets Edge Lower; KB Home Posts Downbeat Results

    Benzinga | Sep. 24, 2014 | 10:49AM EST
  39. Morning Market Movers

    Benzinga | Sep. 24, 2014 | 09:40AM EST
  40. Baxter And Merrimack Pharmaceuticals Enter Into Exclusive Ex-U.S. Licensing Agreement to Develop And Commercialize Novel Cancer Compound MM-398

    Benzinga | Sep. 24, 2014 | 07:01AM EST
  41. FDA Approves Baxter's RIXUBIS For Treatment Of Children With Hemophilia B

    Benzinga | Sep. 15, 2014 | 09:01AM EST
  42. Abbott: A Brighter Future

    GuruFocus | Aug. 28, 2014 | 14:13PM EST
  43. Pfizer To Buy Baxter's Vaccines For $635 Million: The Positives & Negatives

    Benzinga | Aug. 5, 2014 | 09:16AM EST
  44. Halozyme Therapeutics Receives Favorable FDA Decision

    Benzinga | Jul. 31, 2014 | 14:45PM EST
  45. Merck, J&J, Baxter Provide Healthy Dividend Stream

    IBD | Jul. 30, 2014 | 19:01PM EST
  46. Stocks Mixed Despite Better-Than-Expected GDP

    Benzinga | Jul. 30, 2014 | 16:43PM EST
  47. Quarterly “Beats”: Bah, Here Are Real Growers

    YCharts | Jul. 29, 2014 | 21:32PM EST
  48. Diamond Hill Capital Comments on Baxter International Inc

    GuruFocus | Jul. 25, 2014 | 16:55PM EST
  49. Baxter Q2 Earnings Beat Estimates, But Guidance Soft

    IBD | Jul. 17, 2014 | 12:29PM EST
  50. Earnings Scheduled For July 17, 2014

    Benzinga | Jul. 17, 2014 | 05:08AM EST
Trading Center